HIV 1 News and Research

RSS

New CHAIT initiative on development of novel immunological therapeutic interventions

The CHAIT initiative is a public-private partnership focusing on the development of novel immunological therapeutic interventions to achieve a 'functional HIV cure' with the ultimate goal of HIV eradication.

21 Jul 2012

U.S. travel restrictions on sex workers inhibit effective HIV/AIDS response

"[D]isappointingly, one group that will be absent [from the XIX International AIDS Conference next week] due to U.S. travel restrictions is sex workers," a Lancet editorial states.

21 Jul 2012

Domestic PEPFAR program would increase coordination, improve AIDS response in U.S.

"Urban America continues to suffer high rates of HIV despite successes of antiretroviral treatment that can suppress the virus, decrease transmission, prevent progression to AIDS, and lower death rates," Gregory Pappas, senior deputy director of the Washington, D.C., Department of Health's HIV/AIDS, Hepatitis, STD and TB Administration (HAHSTA), writes in a Washington Blade opinion piece.

21 Jul 2012

AIDS 2012 could focus spotlight on efforts against HIV/AIDS in U.S., GlobalPost reports

Noting that Washington, D.C., has an adult HIV prevalence rate higher than some southern African countries that receive PEPFAR funding, GlobalPost writes that the International AIDS Conference, to be held in the U.S. for the first time in 22 years starting Sunday, has highlighted "that America is nowhere close to an AIDS-free generation at home."

21 Jul 2012

60 organizations, Archbishop Tutu call on Obama administration to create 5-year HIV strategy

Sixty organizations and Archbishop Desmond Tutu on Thursday released a "Call for a U.S. Government AIDS-Free Generation Strategic Plan" that "asks the Obama administration to put Secretary of State Hillary Clinton in charge of a task force to complete a [five-year] strategy in time to be announced by the next World AIDS Day -- Dec. 1, 2012," the Center for Global Health Policy's "Science Speaks" blog reports.

21 Jul 2012

South Africa making progress against HIV/AIDS, but still more effort needed, health minister says

Though South Africa has made progress against HIV/AIDS over the past few years, the country's "health minister says much more needs to be done," VOA News reports.

21 Jul 2012

New WHO guidance recommends use of ARVs for HIV prevention

WHO has issued its first guidance to countries that are considering offering HIV medications, known as antiretrovirals (ARVs), to protect people who do not have the virus but who are at high risk of HIV infection.

21 Jul 2012

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

On the eve of the XIX International AIDS Conference in Washington, DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, announces a new collaboration with Indian drug manufacturer Cipla to develop and produce an improved first-line antiretroviral (ARV) combination therapy specifically adapted to meet the treatment needs of infants and toddlers living with HIV/AIDS.

21 Jul 2012

Viewpoints: Creating an HIV-free generation; Postal Service's struggle over retiree health benefits

HIV forces us to deal with so much: sex, drugs, poverty, racism, homelessness, homophobia, sexism, illness and death. While our nation's response has been imperfect, we have gotten a lot right. And we are now at a pivotal moment where science has led us to imagine the possibility of an HIV-free generation.

21 Jul 2012

Study opens way for new approaches to slow development of AIDS in HIV-1-infected patients

A new study from Lund University in Sweden has opened the way for new approaches to slowing the development of AIDS in HIV-1-infected patients. It is hoped that this could lead to better treatment methods and preventive measures to combat HIV and AIDS.

20 Jul 2012

Examining challenges facing Global Fund during its reform

Optimism surrounding the science of HIV treatment and prevention "is tempered by less auspicious trends, particularly shrinking budgets for global health in the U.S. and around the world," Victoria Fan, Amanda Glassman, and Rachel Silverman of the Center for Global Development (CGD) write in the center's "Global Health Policy" blog.

20 Jul 2012

Peace Corps Volunteers provide HIV/AIDS prevention, awareness

Carrie Hessler-Radelet, deputy director of the Peace Corps, discusses the agency's work in HIV/AIDS prevention, care, and support in an AIDS.gov blog post. "Last year alone, 52 percent of all Peace Corps Volunteers engaged in such work in communities overseas," she writes, noting, "In 2013, through the Global Health Service Partnership, we look forward to placing doctors and nurses as adjunct faculty in training institutions in Africa."

20 Jul 2012

Funding must support optimism surrounding HIV prevention, treatment

The goal of an "AIDS-free generation" "requires an ambitious implementation-science agenda that improves efficiency and effectiveness and incorporates strategies for overcoming the stigma and discrimination that continue to limit the uptake and utilization of treatment, prevention and care services," AIDS 2012 Co-Chair Diane Havlir of the University of California-San Francisco School of Medicine and Chris Beyrer of the Johns Hopkins Center for AIDS Research write in a New England Journal of Medicine opinion piece.

20 Jul 2012

American leadership on HIV/AIDS making a difference in U.S. and abroad

"As two people who worked as physicians in the early years of the HIV/AIDS epidemic before the miracle of antiretroviral drug (ARV) therapy, and who now have the honor of leading the domestic and global HIV/AIDS programs for the Obama administration, we look back in awe of the American leadership that has transformed the epidemic in the 22 years since the International AIDS Conference was last held on U.S. soil," Grant Colfax, director of the Office of National AIDS Policy, and U.S. Global AIDS Coordinator Ambassador Eric Goosby write in a Washington Blade opinion piece.

20 Jul 2012

Natural compound can virtually eradicate HIV in infected culture cells

A new study by scientists on the Florida campus of The Scripps Research Institute shows, in cell culture, a natural compound can virtually eliminate human immunodeficiency virus (HIV) in infected cells. The compound defines a novel class of HIV anti-viral drugs endowed with the capacity to repress viral replication in acutely and chronically infected cells.

20 Jul 2012

Keystone Symposia on Molecular and Cellular Biology receives Gates Foundation grant

Keystone Symposia on Molecular and Cellular Biology is pleased to announce that it has received a fourth grant from the Bill & Melinda Gates Foundation to promote discoveries that will solve urgent global health problems via support of infectious disease conferences in the "Keystone Symposia Global Health Series."

20 Jul 2012

UNAIDS releases report highlighting gains, gaps in global HIV/AIDS response

Ahead of the XIX International AIDS Conference next week, UNAIDS on Wednesday launched a new report, titled "Together we will end AIDS", "that shows that a record eight million people are now receiving antiretroviral therapy [ARVs], and that domestic funding for HIV has exceeded global investments," the U.N. News Centre reports.

20 Jul 2012

HIV epidemic in MSM could be helped by better interaction with their health system

The second paper in The Lancet Series on HIV in MSM focuses on clinical care, and says that optimum clinical care for sexual and gender minorities is a fundamental human right. “MSM deserve to be treated with respect, and health-care providers need to interact with them in ways that promote disclosure of actionable health information,” say the authors, led by Dr Ken Mayer, Fenway Health, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

20 Jul 2012

HIV in MSM increasing in countries of all incomes

A new Lancet Series published to coincide with the AIDS2012 meeting highlights a population where the HIV epidemic is growing in countries of all incomes: men who have sex with men (MSM). The first paper in the Series charts the epidemiology of HIV among MSM, and is by Professor Chris Beyrer, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, and colleagues.

20 Jul 2012

ARV drug resistance levels steady in low-, middle-income countries, WHO report says

More widespread use of antiretroviral drugs (ARVs) to treat HIV infection has led to drug resistance in low- and middle-income countries, but the level "is not steep enough to cause alarm, said a survey released by the World Health Organization on Wednesday," Agence France-Presse reports.

20 Jul 2012

HIV 1 News and Research

New CHAIT initiative on development of novel immunological therapeutic interventions

U.S. travel restrictions on sex workers inhibit effective HIV/AIDS response

Domestic PEPFAR program would increase coordination, improve AIDS response in U.S.

AIDS 2012 could focus spotlight on efforts against HIV/AIDS in U.S., GlobalPost reports

60 organizations, Archbishop Tutu call on Obama administration to create 5-year HIV strategy

South Africa making progress against HIV/AIDS, but still more effort needed, health minister says

New WHO guidance recommends use of ARVs for HIV prevention

Cipla, DNDi to develop ARV combination therapy for children with HIV/AIDS

Viewpoints: Creating an HIV-free generation; Postal Service's struggle over retiree health benefits

Study opens way for new approaches to slow development of AIDS in HIV-1-infected patients

Examining challenges facing Global Fund during its reform

Peace Corps Volunteers provide HIV/AIDS prevention, awareness

Funding must support optimism surrounding HIV prevention, treatment

American leadership on HIV/AIDS making a difference in U.S. and abroad

Natural compound can virtually eradicate HIV in infected culture cells

Keystone Symposia on Molecular and Cellular Biology receives Gates Foundation grant

UNAIDS releases report highlighting gains, gaps in global HIV/AIDS response

HIV epidemic in MSM could be helped by better interaction with their health system

HIV in MSM increasing in countries of all incomes

ARV drug resistance levels steady in low-, middle-income countries, WHO report says

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News